Lantern Pharma announces up to $8M registered direct offering (LTRN:NASDAQ)
· seekingalpha.com
Lantern Pharma (LTRN) announces a $4M registered direct offering and private placement warrants priced at $1.09, expected to close Sept.
To ensure this doesn’t happen in the future, please enable Javascript and cookies in your browser.
If you have an ad-blocker enabled you may be blocked from ...